论文部分内容阅读
作者应用胎鼠肝细胞生物活性法测定11例慢性肾功能衰竭(CRF)患者CAPD前后的血清红细胞生成素(EP)并同时测定血红蛋白浓度,血清EP从透析前33.94土4.63U/L升至透析后48.03±5.85U/L,血红蛋白浓度从49.3±3.2g/L升至57.6±3.9g/L.并初步探讨了CAPD前后EP及血红蛋白浓度升高的机理.
The authors used fetal rat hepatocyte bioassay to determine serum erythropoietin (EP) in 11 patients with chronic renal failure (CRF) before and after CAPD and measured hemoglobin concentration. Serum EP rose from 4.63U / L before dialysis to dialysis After 48.03 ± 5.85U / L, hemoglobin concentration increased from 49.3 ± 3.2g / L to 57.6 ± 3.9g / L, and the mechanism of EP and hemoglobin concentration before and after CAPD was preliminarily discussed.